Litcius/Paper detail

RNA aggregates harness the danger response for potent cancer immunotherapy

Héctor R. Méndez‐Gómez, Anna DeVries, Paul Castillo, Christina A. Von Roemeling, Sadeem Qdaisat, Brian Stover, Chao Xie, Frances Weidert, Chong Zhao, Rachel Moor, Ruixuan Liu, Dhruvkumar Soni, Elizabeth Ogando‐Rivas, Jonathan Chardon‐Robles, James McGuiness, Dingpeng Zhang, Michael C. Chung, Christiano Marconi, Stephen Michel, Arnav Barpujari, Gabriel Jobin, Nagheme Thomas, Xiaojie Ma, Yodarlynis Campaneria, Adam Grippin, Aida Karachi, Derek Li, Bikash Sahay, Leighton Elliott, Timothy P. Foster, Kirsten E. Coleman, Rowan J. Milner, W. Gregory Sawyer, John A. Ligon, Eugenio Simon, Brian Cleaver, Kristine Wynne, Marcia Hodik, Annette M. Molinaro, Juan Guan, Patrick Kellish, Andria Doty, Ji‐Hyun Lee, Tara Massini, Jesse Kresak, Jianping Huang, Eugene I. Hwang, Cassie Kline, Sheila Carrera‐Justiz, Maryam Rahman, Sebastián Gatica, Sabine Mueller, Michael D. Prados, Ashley Ghiaseddin, Natalie L. Silver, Duane A. Mitchell, Elias Sayour

2024Cell132 citationsDOIOpen Access PDF

Topics & Concepts

BiologyCancer immunotherapyRNAImmunotherapyComputational biologyCancerCancer researchGeneticsGeneinterferon and immune responsesImmunotherapy and Immune ResponsesRNA Interference and Gene Delivery
RNA aggregates harness the danger response for potent cancer immunotherapy | Litcius